BioHarvest Sciences
BHST
BioHarvest Sciences (BHST) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Roth Capital | Maintained | Buy | $8.00 from $10.00 | Aug 12, 2026 |
| Maxim Group | Maintained | Buy | $5.00 from $12.00 | Aug 12, 2026 |
| Roth Capital | Initiated Coverage | Buy | $10.00 | Feb 19, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $14.00 | Apr 8, 2025 |
| Maxim Group | Initiated Coverage | Buy | $12.00 | Dec 18, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $14.00 | Dec 11, 2024 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $14.00 | Dec 6, 2024 |
Frequently asked questions
What is the latest analyst rating on BHST?
On Aug 12, 2026, Roth Capital maintained BioHarvest Sciences at Buy with a price target of $8.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.